Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol and Hydrocortisone for Acute Stress Reactions
NCT06982183Phase 4Recruiting
- Sponsor
- Walter Reed Army Institute of Research
- Start
- May 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol, hydrocortisone in acute stress reaction (ASR), specific phobia, sponsored by Walter Reed Army Institute of Research. Started May 2025; status: recruiting.
02
Drugs
propranololhydrocortisone
03
Conditions
acute stress reaction (ASR)specific phobia
Beyond the preview
Go deeper on NCT06982183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06982183.